Cholangiocarcinoma: Current Knowledge and New Developments
Author:
Affiliation:
1. Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Publisher
The Editorial Office of Gut and Liver
Subject
Gastroenterology,Hepatology
Link
http://pdf.medrang.co.kr/GNL/2017/011/ekjg011-01-07.pdf
Reference89 articles.
1. Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas
2. Risk factors for cholangiocarcinoma
3. Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?
4. Secular Trends in the Incidence of Cholangiocarcinoma in the USA and the Impact of Misclassification
5. Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival
Cited by 360 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of photodynamic therapy on peripheral immune system for unresectable cholangiocarcinoma;Photodiagnosis and Photodynamic Therapy;2024-10
2. Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US;The Oncologist;2024-08-21
3. Hybrid FDG-PET/MRI for Diagnosis and Clinical Management of Patients with Suspected Perihilar Cholangiocarcinoma: A Feasibility Pilot Study;Nuclear Medicine and Molecular Imaging;2024-08-01
4. Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity;ESMO Open;2024-08
5. The Effect of Yinchenhao Decoction on the Pharmacokinetic Profile of Futibatinib by HPLC-MS/MS;Separations;2024-07-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3